Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.
Business Insider on MSN6d
The FDA is about to make weight-loss drugs a lot harder to getLots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.
Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...
Medpage Today on MSN11d
Online Sellers of Compounded GLP-1s Often Don't Mention RisksHalf of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...
While semaglutide is still on the shortage ... the FDA put the drugs on its shortage list in 2022. This allowed compounding pharmacies to get into the GLP-1 game by creating their own versions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback